Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study. by Sonja M Bjerk, Jason V Baker, Sean Emery, Jacqueline Neuhaus, Brian Angus, Fred M Gordin, Sarah L Pett, Christoph Stephan, Ken M Kunisaki, INSIGHT SMART Study Group

Get full text

The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies. by Richard T Davey, Ruth Lynfield, Dominic E Dwyer, Marcello H Losso, Alessandro Cozzi-Lepri, Deborah Wentworth, H Clifford Lane, Robin Dewar, Adam Rupert, Julia A Metcalf, Sarah L Pett, Timothy M Uyeki, Jose Maria Bruguera, Brian Angus, Nathan Cummins, Jens Lundgren, James D Neaton, INSIGHT FLU 002 & 003 Study Groups

Get full text

Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus. by Aminata Sy, Leanne McCabe, Emma Hudson, Azim M Ansari, Vincent Pedergnana, Shang-Kuan Lin, S Santana, Marzia Fiorino, Aftab Ala, Ben Stone, M Smith, Mark Nelson, Stephen T Barclay, Stuart McPherson, Stephen D Ryder, Jane Collier, Eleanor Barnes, Ann Sarah Walker, Sarah L Pett, Graham Cooke, STOP-HCV-1 trial team

Get full text

Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial. by Cissy Kityo, Alexander J Szubert, Abraham Siika, Robert Heyderman, Mutsa Bwakura-Dangarembizi, Abbas Lugemwa, Shalton Mwaringa, Anna Griffiths, Immaculate Nkanya, Sheila Kabahenda, Simon Wachira, Godfrey Musoro, Chatu Rajapakse, Timothy Etyang, James Abach, Moira J Spyer, Priscilla Wavamunno, Linda Nyondo-Mipando, Ennie Chidziva, Kusum Nathoo, Nigel Klein, James Hakim, Diana M Gibb, A Sarah Walker, Sarah L Pett, REALITY trial team

Get full text